High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women

Journal of Clinical Lipidology

Volumn 2, Issue 4, 2008, Pages 298-303

  Roest, Mark ^a   Voorbij, Hieronymus A M ^a   Van der Schouw, Yvonne T ^a   Peeters, Petra H M ^a   Teerlink, Tom ^b   Scheffer, Peter G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Cohort study; Coronary heart disease; F2 isoprostanes; Mass spectrometry; Prostaglandin; Stroke

Indexed keywords

INSULIN; ISOPROSTANE DERIVATIVE; ORAL ANTIDIABETIC AGENT; PROSTAGLANDIN F2 ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DIABETIC DIET; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 48549106250     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.06.004     Document Type: Article

References (20)

1. Okrainec K., Banerjee D.K., and Eisenberg M.J. Coronary artery disease in the developing world. Am Heart J 148 (2004) 7-15
2. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91 (2003) 7A-11A
3. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 25 (2005) 279-286
4. Richelle M., Turini M.E., Guidoux R., Tavazzi I., Metairon S., and Fay L.B. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 459 (1999) 259-262
5. Pratico D. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 147 (1999) 1-10
6. Yan W., Byrd G.D., and Ogden M.W. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res 48 (2007) 1607-1617
7. Reilly M., Delanty N., Lawson J.A., and FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
8. Davi G., Alessandrini P., Mezzetti A., et al. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 17 (1997) 3230-3235
9. Reilly M.P., Pratico D., Delanty N., et al. Increased formation of distinct F-2 isoprostanes in hypercholesterolemia. Circulation 98 (1998) 2822-2828
10. Davi G., Gresele P., Violi F., et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96 (1997) 69-75
11. Hirsch S., Ronco A.M., Vasquez M., et al. Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. J Nutr 134 (2004) 1832-1835
12. Schwedhelm E., Bartling A., Lenzen H., et al. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 109 (2004) 843-848
13. Monninkhof E.M., Van der Schouw Y.T., and Peeters P.H. Early age at menopause and breast cancer: are leaner women more protected?. A prospective analysis of the Dutch DOM cohort. Breast Cancer Res Treat 55 (1999) 285-291
14. Roest M., Banga J.D., Janssen W.M., et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103 (2001) 3057-3061
15. Bohnstedt K.C., Karlberg B., Wahlund L.O., Jonhagen M.E., Basun H., and Schmidt S. Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 796 (2003) 11-19
16. Gross M., Steffes M., Jacobs Jr. D.R., et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem 51 (2005) 125-131
17. Keaney J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
18. Milne G.L., Yin H., Brooks J.D., Sanchez S., Jackson R.L., and Morrow J.D. Quantification of f2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 433 (2007) 113-126
19. Ohashi N., and Yoshikawa M. Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 746 (2000) 17-24
20. Roberts L.J., and Morrow J.D. The generation and actions of isoprostanes. Biochim Biophys Acta 1345 (1997) 121-135